Detalhe da pesquisa
1.
Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus.
PLoS Pathog
; 20(2): e1011976, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315728
2.
The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
J Virol
; 98(5): e0042424, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629837
3.
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure.
Am J Physiol Cell Physiol
; 325(1): C129-C140, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37273239
4.
Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.
J Virol
; 96(4): e0211721, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935441
5.
Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study.
Infection
; 51(4): 1093-1102, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913112
6.
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis.
Int J Mol Sci
; 24(5)2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902395
7.
The Epidermal Growth Factor Receptor Is a Relevant Host Factor in the Early Stages of The Zika Virus Life Cycle In Vitro.
J Virol
; 95(20): e0119521, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379506
8.
Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.
J Virol
; 95(7)2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472929
9.
Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe.
Allergy
; 77(1): 72-82, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887070
10.
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.
Allergy
; 77(7): 2053-2066, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637150
11.
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses.
Allergy
; 77(7): 2080-2089, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820854
12.
Hepatitis E virus egress and beyond - the manifold roles of the viral ORF3 protein.
Cell Microbiol
; 23(12): e13379, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272798
13.
[Overview of COVID-19 vaccines licensed in the EU-from technology via clinical trial to registration]. / Übersicht über die in der EU zugelassenen COVID-19-Impfstoffe von der Technologie über die klinische Prüfung zur Zulassung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(12): 1237-1243, 2022 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-36257986
14.
[Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis]. / Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 228-237, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-35015106
15.
[Viral hepatitis A to E: prevalence, pathogen characteristics, and pathogenesis]. / Die Virushepatitiden A bis E: Prävalenz, Erregermerkmale und Pathogenese.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 139-148, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-34932130
16.
[Batch testing as an essential pillar of the supply of safe and effective vaccines]. / Chargenprüfung als wesentliche Säule der Versorgung mit sicheren und wirksamen Impfstoffen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(12): 1244-1250, 2022 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-36264321
17.
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection.
Liver Int
; 41(6): 1278-1289, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33786970
18.
[Licensing procedures for human vaccines in Germany and Europe and the WHO prequalification program]. / Zulassungsverfahren für Humanimpfstoffe in Deutschland und Europa und das Präqualifizierungsprogramm der WHO.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 63(1): 4-15, 2020 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-31776598
19.
[Immunotherapies for the treatment of chronic hepatitis B virus infections-an overview with a focus on CAR T cells]. / Immuntherapien zur Behandlung der chronischen Hepatitis-B-Virusinfektion eine Übersicht unter besonderer Berücksichtigung von CAR-T-Zellen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 63(11): 1357-1364, 2020 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-32995895
20.
New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release.
Gut
; 73(4): 566-567, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253479